Amarin CEO Thero On Gearing Up For Success Ahead Of The Big Vascepa Ad Comm

"We're planning for success," John Thero told Scrip in an interview, where he talked about the upcoming US advisory committee meeting for Vascepa, commercial expansion plans and deflected questions about a big pharma buyout.

Detour warning sign on the pedestrians footpath surface in Sydney city CBD, Australia - Image
Amarin has one big FDA review meeting to go

More from New Products

More from Scrip